Patents by Inventor Keith M. Pietropaolo

Keith M. Pietropaolo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY
    Publication number: 20240148770
    Abstract: A synergistic pharmaceutical combination of Compound 1 or a pharmaceutically acceptable salt thereof (e.g.
    Type: Application
    Filed: December 14, 2023
    Publication date: May 9, 2024
    Applicant: Atea Pharmaceuticals, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa, Keith M. Pietropaolo, Xiao-Jian Zhou
  • Treatment of HCV infected patients with cirrhosis
    Patent number: 11690860
    Abstract: A pharmaceutical composition that includes a compound of the structure: to treat an HCV infected patient with cirrhosis, and uses thereof.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: July 4, 2023
    Assignee: Atea Pharmaceuticals, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa, Keith M. Pietropaolo, Xiao-Jian Zhou
  • TREATMENT OF HCV INFECTED PATIENTS WITH CIRRHOSIS
    Publication number: 20210015841
    Abstract: A pharmaceutical composition that includes a compound of the structure: to treat an HCV infected patient with cirrhosis, and uses thereof.
    Type: Application
    Filed: October 7, 2020
    Publication date: January 21, 2021
    Applicant: Atea Pharmaceuticals, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa, Keith M. Pietropaolo, Xiao-Jian Zhou